Volume 22; Issue 5

Main
Journla of Immunotherapy
Volume 22; Issue 5

Journla of Immunotherapy

Volume 22; Issue 5

1

IL-12/PULSE IL-2 INDUCES ENDOTHELIAL INJURY, INHIBITS TUMOR NEOVASCULARIZATION, AND INDUCES COMPLETE TUMOR REGRESSION VIA MECHANISMS DEPENDENT ON CD8 T CELLS AND FAS-L

Wigginton, J M, Park, J W, Back, T C, Gieselhart, L, Wiltrout, T A, Sayers, T, McCormick, K, Wiltrout, R H

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 102 KB

1999

2

EFFECTS OF PAROXETINE ON CYTOKINE RELEASE AND DEPRESSION INDUCED BY INTERFERON ALFA-2B

MUSSELMAN, D. L., LAWSON, D. H., PENNA, S., GREINER, K., PEARCE, B. D., NEMEROFF, C. B., MILLER, A. H.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

3

MAJOR PHENOTYPIC, MORPHOLOGIC AND FUNCTIONAL DIFFERENCES BETWEEN DCs STIMULATED WITH MONOCYTE-CONDITION MEDIUM OR CYTOKINE COCKTAIL

Mailliard, Robbie B., Lotze, Michael T.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

4

IIB-MEL-J ALLOGENEIC TUMOR CELL VACCINE CONTAINS GRP94, AN IMMUNOSTIMULATORY HEAT SHOCK PROTEIN

Malone, C, Mackintosh, A D, Schiltz, P M, Beutel, L, Spencer, K, McGee, JMC, Dillman, R O

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 107 KB

1999

5

IgG vs IgM ANTIBODIES IN RECIPIENT SERA AGAINST ANTIGENS IN A MELANOMA VACCINE

McGee, J M, Mayes, J S, n, Patte, Mathias, C, Watson, G H, Albertson, R M, Boyle, M J, Broughan, T A

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 105 KB

1999

6

HIGH FREQUENCIES OF TUMOR-REACTIVE CD8+ T CELLS IN MELANOMA AND COLON CANCER PATIENTS

Scheibenbogen, Carmen, Letsch, Anne, Schmittel, Alexander, Thiel, Eckhard, Keilholz, Ulrich

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

7

SERUM ANTIBODIES LEVELS (AB) TO SK-MEL-24 CELLS IN MELANOMA PATIENTS TREATED WITH INTRALYMPHATIC WHOLE-CELL TUMOR VACCINE

Kudinov, Y. G., Kharazi, A. I., Berliner, K. I., Wiseman, C. L.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 111 KB

1999

8

INTRAPERITONEAL TREATMENT OF OVARIAN CANCER WITH DAUNORUBICIN ANTIBODY CONJUGATES

M, Pagé, P., Lemieux

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 108 KB

1999

9

CHARACTERIZATION OF PERIPHERAL BLOOD MONOCY DERIVED DENDRITIC CELLS GENERATED WITH INTERFERON AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATIN FACTOR

Egawa, S., Mailliard, R., Lotze, M. T.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 107 KB

1999

10

A Phase I Trial of an HLA-A1 Restricted MAGE-3 Epitope Peptide with Incomplete Freundʼs Adjuvant in Patients with Resected High-Risk Melanoma

Weber, Jeffrey S., Hua, Flora L., Spears, Lucy, Marty, Verna, Kuniyoshi, Catherine, Celis, Esteban

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 883 KB

1999

11

SENSITIVITY TO y-INTERFERON (y-IFN) AS A CRITERION FOR SELECTION OF CELL LINES FOR ALLOGENEIC CELL TUMOR VACCINE TREATMENT

Kharazi, A. I., Kudinov, Y. G., Huang, C., Wiseman, C. L.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 111 KB

1999

12

THE EX VIVO CULTURE OF HUMAN MYELOID-DENDRITIC CELLS (DC) IN RESPONSE TO L-ASCORBIC ACID (LAA) VS. LIPOPOLYSACCHARIDE (LPS)

Lee, H A, Back, S. Y., Lee, H. G., Yoon, S-S, Kim, W. S., Kang, W. K., Park, K., Park, C., Park, M. H., Park, C. H.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

13

THE ANTITUMOR ACTIVITY OF IL-18/IL-2

Wigginton, J M, Wiltrout, T A, Smith, J, Back, T C, Wiltrout, R H

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 102 KB

1999

14

INTRATUMORAL INJECTION OF A CANARYPOX VIRUS ENCODING HUMAN (ALVAC-IL-12) IN MELANOMA PATIENTS

Conry, R. M., Bonnet, M. C., Allen, K., Barlow, D., Lobuglio, A. F.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

15

CISPLATIN ENHANCE THE ANTITUMOR EFFECT OF HSVTK/GC GENE THERAPY FOR HUMAN HEPATOCELLUALR CARCINONMA

Feng, Xuesheng, Tang, Zhaoyou, Ke, Kai, Zheng, Zhongcheng, Liu, Xinyuan

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 106 KB

1999

16

ACTIVATED-HUMAN DENDRITIC CELLS (DCs) DECREASE PRODUCTION OF PROANGIOGENIC FACTORS WITH PROGRESSIVE MATURATION

x, Odou, s, Alber, Lotze, M. T.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

17

IL-12 POTENTIATES THE THERAPEUTIC ACTIVITY OF BCG

OʼDonnell, MA, Luo, Y, Chen, X, Clinton, S K

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

18

Prolonged Skin Graft Survival by Administration of Anti-CD8C Monoclonal Antibody with Cyclosporin A

Ossevoort, Miriam A., Lorré, Katrien, Boon, Louis, van den Hout, Yvon, de Boer, Mark, Waele, Peter De, Jonker, Margreet, Voorde, Andre Vande

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 793 KB

1999

19

Protein Transfer of Glycosyl-Phosphatidylinositol (GPI)-Modified Murine B7–1 and B7–2 Costimulators

Brunschwig, Elaine B., Fayen, John D., Medof, M. Edward, Tykocinski, Mark L.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 967 KB

1999

20

In Vivo Binding and Antitumor Activity of Ch 14.18

Kendra, Kari, Malkovska, Vera, Allen, Mark, Guzman, Jose, Albertini, Mark

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 707 KB

1999

21

Maximizing antigen presentation of GP100 using adenoviral vectors

Boutin, P., Shankara, S., Nicolette, C., Roberts, B.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 117 KB

1999

22

THE USE OF SHORT-TERM CULTURES OF AUTOLOGOUS TUMOR CELLS FOR CANCER VACCINE

Dilman, R O, Beutel, L D, Schiltz, P M, Cornforth, A N, Nayak, S K

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 107 KB

1999

23

EXPRESSION OF PROSTATE SPECIFIC MOLECULES IN BCG-POTENTIAL FOR IMMUNOTHERAPY

Zeoli, C., Werber, J., Peretz, G., Bizgia, J., Maitland, M., Bloom, B., Rose, H., Mittelman, A., Geliebter, J.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 105 KB

1999

24

UPDATE ON IDEC-Y2B8 (ZEVALIN) RADIOIMMUNOTHERAPY OF B-CELL NHL

Gordon, L. I., White, C. A., Witzig, T. E., Wiseman, G. A., Grillo-López, A. J.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 105 KB

1999

25

BCG EXPRESSING HUMAN INTERFERON-ALPHA 2B DEMONSTRATES ENHANCED IMMUNOGENICITY

Luo, Y, Chen, X, DeWolf, W C, OʼDonnell, M A

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

26

EFFECTS OF IN VITRO AND IN VIVO HYPERTHERMIC TREATMENTS ON THE MITOGEN INDUCED PRODUCTION OF INTERLEUKIN 2 AND INTERFERON y FROM MURINE LYMPHOCYTE POPULATIONS

Pritchard, M., Repasky, E. A.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 118 KB

1999

27

HISTAMINE DIHYDROCHLORIDE (MAXAMINE) AS ADJUVANT THERAPY TO IMMUNOTHERAPY IN CANCER

Gehlsen, K. R., Naredi, P., Brune, M., Hellstrand, K.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 106 KB

1999

28

Therapeutic Effect of a New Synthetic Lipid A Analog (ONO-4007) on a Tumor Implanted at Different Sites in Rats

Mizushima, Yutaka, Sassa, Kazuhiko, Fujishita, Takashi, Oosaki, Rokuo, Kobayashi, Masashi

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 420 KB

1999

29

NEOADJUVANT BIOCHEMOTHERAPY FOR STAGE I AND RESECTABLE STAGE IV MALIGNANT MELANOM (MM)

P, Gibbs, C, Anderson, N, Pearlman, M, Becker, K, McDowell, R, Gonzalez

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 105 KB

1999

30

SUCCESSFUL TREATMENT OF REFRACTORY HEMATOLOGIC MALIGNANCY (HM) BY NONABLATIVE BMT

Rubin, A. D., Ojha, R., Motaseb, H., Hajjar, G., Rubin, G. H., Todd, D.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 107 KB

1999

31

Effect of hGrb 10 On Growth And Insulin-like Growth Factor Signaling In Breast Cancer Cells

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 117 KB

1999

32

Hyperthermic Antiblastic Perfusion with Alpha Tumor Necrosis Factor and Doxorubicin for the Treatment of Soft Tissue Limb Sarcoma in Candidates for Amputation

Filippo, Franco Di, Rossi, Carlo R., Vaglini, Maurizio, Azzarelli, Alberto, Anzà, Michele, Santinami, Mario, Lise, Mario, Cavaliere, Francesco, Giannarelli, Diana, Quagliuolo, Vittorio, Vecchiato, Ant

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 648 KB

1999

33

Immunity to Breast Cancer in Mice Immunized with X-Irradiated Breast Cancer Cells Modified to Secrete IL-12

Carr-Brendel, Victoria, Markovic, Dubravka, Smith, Michael, Taylor-Papadimitriou, Joyce, Cohen, Edward P.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 661 KB

1999

34

TETRACYCLINE-CONTROLLED POSITIVE FEEBACK REGULATORY SYSTEM (PFRS)

Agha-Mohammadi, Siamak

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 70 KB

1999

35

INCREASING EFFECTS OF INTERFERONS(IFNs)-a ANI IFN-β THROUGH SIGNAL TRANSDUCTION

Sarkar, M. Chawla, Leaman, D., Borden, E.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 117 KB

1999

36

The effect of growth inhibition by LGD1550 on retinoid-resistant ovarian cancer cell lines

W, Hu, C, Verschraegen, WG, Wu, J, Mendoza, RS, Freedman, A, Kudelka, JJ, Kavanagh

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 111 KB

1999

37

A NOVEL METHOD TO REMOVE TUMOR MASS

Massey, R D, Weichold, F, Netski, D, Pardini, R, Maciejewski, J

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 105 KB

1999

38

DEVELOPMENT OF A VACCINE THAT TARGETS FGF-2 TO INHIBIT ANGIOGENESIS AND TUMOR GROWTH

Plum, S. M., Ruiz, A. R., Madsen, J., Fogler, W. E., Fortier, A. H.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 109 KB

1999

39

IL-12 SYNERGIZES WITH MHC CLASS II/B7.1-CELL BASED VACCINES T STIMULATE IMMUNE EFFECTORS AND ANTI-ANGIOSTATIC MECHANISM THAT REDUCE ESTABLISHED METASTATIC DISEASE

Pulaski, B A, Clements, V, Pipeling, M, Ostrand-Rosenberg, S

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 109 KB

1999

40

SDF-1 MEDIATED IMMUNE EFFECTOR CELL RECRUITMENT USING HSV AMPLICON VECTORS

Tolba, Khaled, Federoff, Howard J., Halterman, Mark, Newman, Corliss, Challita-Eid, Pia, Rosenblatt, Joseph D.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 107 KB

1999

41

DETECTION OF HUMAN ENDOGENOUS RETROVRUS, HERV-E 4–1, ENVELOPE MRNA EXPRESS DN IN PROSTATE ADENOCARCNOMA

Wang-Johanning, F., Khazeali, M B., Strong, TV., LoBuglo, AF.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 117 KB

1999

42

A NOVEL HLA-DR-RESTRICTED MELAN-A/MART-1 ANTIGEN REPRESENTS AN IMMUNOGENIC EPITOPE RECOGNIZED BY MELANOMA-SPECIFIC CD4+ T CELLS

Zarour, Hassane M., Storkus, Walter J., Kirkwood, John M.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 34 KB

1999

43

Immunoadsorption in Multifocal Motor Neuropathy

Finsterer, Josef, Derfler, Kurt

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 136 KB

1999

44

The Immunotherapeutic Potential of Activated Canine Alveolar Macrophages and Antitumor Monoclonal Antibodies in Metastatic Canine Melanoma

Soergel, Steve A., MacEwen, E. Gregory, Vail, David M., Potter, David M., Sondel, Paul M., Helfand, Stuart C.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 1006 KB

1999

45

Kinetics of Tetracycline-Regulatable System (TRS) in Response to Tetracycline Derivatives

Agha-Mohammadi, Siamak

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 70 KB

1999

46

IMMUNOGENICITY AND ANTITUMOR ACTIVITY OF MUCI BASED VACCINE, LIPOSOMAL BLP25

Budzynski, W. A., Krantz, M. J., Parker, J., Agrawal, B., Longenecker, B. M.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 119 KB

1999

47

NEUTROPHIL GRANULE PEPTIDES DEFENSINS INDUCE DEVELOPMENT OF MATURE DENDRITIC CELLD FROM HUMAN CD34+ STEM CELLS

Bykovskaia, S. N., Shogan, J. I., Bunker, M., Buffo, M. Jo, Shurin, G., Chertov, O., Oppenheim, J. J.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

48

AN ANTI-HER2/neu RANTES FUSION PROTEIN INDUCES EFFECTOR CELL INFILTRATION WITHIN HER2/neu EXPRESSING TUMORS

Challita-Eid, P M, Hilchey, S P, Rosenblatt, J D

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 114 KB

1999

49

IN VITRO SENSITIZATION TO HUMAN PAPILLOMAVIRUS TYPE 18 PEPTIDES

Castellanos, M. R., Maiman, M. A., Hayes, R. L.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

50

INACTIVATION OF DECAY-ACCELERATOR ACTIVITY OF FACTOR H BY MONOCLONAL ANTIBODIES

Corev, M J, Hass, G M, Vessella, R L, Kinders, R J

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 107 KB

1999

51

A PHASE II STUDY OF CONTINUOUS LOW DOSE THALIDOMIDE IN PATIENTS WITH RENAL CELL. MELANOMA, OVARIAN AND BREAST CANCER

Eisen, T, Boshoff, C, Mak, I, Pyle, L, Johnston, S, Ahem, R, Smith, I E, Gore, M E

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 107 KB

1999

52

ONTAK (DAB389IL-2)

Foss, F M, Kuzel, T, LeMaistre, C F, Duvic, M

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 107 KB

1999

53

SERUM IL-6 REDUCTION AFTER VACCINATION OF BREAST CANCER PATIENTS WITH TUMOR-ASSOCIATED ANTIGENS IS RELATED TO ESTROGEN RECEPTOR STATUS

Jiang, X. P., Yang, D. C., Elliott, R. L., Head, J. F.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 105 KB

1999

54

COMBINING MAb 17–1A WITH GM-CSF AND IL-2 IN ADVANCED COLORECTAL CARCINOMA (CRC)

Skog, A-L Hjelm, Ragnhammar, P, Fagerberg, J, Frödin, J-E, Liljefors, M, Shetye, J, Wersäll, P, Mellstedt, H

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 111 KB

1999

55

TUMOR-SELECTIVE SALMONELLA AS A GENE DELIVERY VECTOR FOR CANCER GENE THERAPY

-M., Zheng L., o, Lu, Z., Li., Le, Ittensohn M.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

56

A CRITIQUE OF STUDIES OF MURINE MODELS USED TO ANALYZE HOST IMMUNE RESPONSES DURING PROGRESSIVE TUMOR GROWTH

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 105 KB

1999

57

A COMPREHENSIVE APPROACH TO HIGH-THROUGHPUT ANTIGEN IDENTIFICATION AND OPTIMIZATION

Nicolette, C., Lawendowski, C., Giurleo, G., Huang, Y., Shankara, S., Boutin, P., Demkowicz, W., Wu, L., Swistak, M., Roberts, B.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 106 KB

1999

58

CO-ADMINISTRATION OF INTERFERON-ALPHA 2B WITH BCG IS EFFECTIVE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER PREVIOUSLY FAILING BCG ALONE

OʼDonnell, M A, Downs, T M, DeWolf, W C

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

59

ANTITUMOR EFFECTS OF ANGIOZYME RIBOZYME TARGETING THE VEGF RECEPTOR FLT

Parker, V. P., Bouhana, K. S., Pavco, P. A., Blancha, K. S., Parry, T. J., Blatt, L. M., Sandberg, J. A.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 109 KB

1999

60

EFFECTS OF FEVER-LIKE WHOLE BODY HYPERTHERMIA ON LPS INDUCED ACUTE PHASE REACTIONS

Ostberg, J. R., Baumann, H., Repasky, E. A.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 116 KB

1999

61

FEVER-LIKE WHOLE BODY HYPERTHERMIA ENHANCES THE ANTI-TUMOR EFFECT OF ENCAPSULATED LIPOSOMAL DOXORUBICIN IN MOUSE MODELS FOR THE GROWTH OF HUMAN AND MURINE COLON TUMORS

Xu, Y., Bull, J. M., Colbem, G., Repasky, E. A.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 116 KB

1999

62

TARGETED INHIBITION OF THE Na/H EXCHANGER RESULTS IN MASSIVE APOPTOSIS OF LEUKEMIC CELLS

Rich, I N, Musk, Philip, Worthington-White, D

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 116 KB

1999

63

IDENTIFICATION AND CHARACTERIZATION OF NOVEL TARGETS FOR DEVELOPING CANCER SPECIFIC THERAPEUTIC ANTIBODIES

Roschke, Viktor, Barash, Steve, Subbotin, Vladimir, Soppet, Dan, Choi, Gil, Birse, Charlie, Young, Paul, Giri, Judith, Garotta, Gianni, Ruben, Steve

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 107 KB

1999

64

Helper-Free Herpes Simplex Virus Amplicons allow Efficient Transduction of Leukemia Cells with a costimulatory ligand without Loss of MHC-I Expression

Tolba, Khaled, Federoff, Howard J., Bowers, William, Facciponte, John, Baka, Jennifer, Challita-Eid, Pia, Rosenblatt, Joseph D.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 107 KB

1999

65

MAGE PEPTIDE BASED IMMUNOTHERAPY FOR GASTRO-INTESTINAL CANCER

Sadanaga, N., Nagashima, H., Mashino, K., Tahara, K., Fujie, T., Tanaka, F., Akiyoshi, T., Mori, M.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 110 KB

1999

66

TUMOR INFILTRATING LYMPHOCYTES (TIL) GENERATED FROM MELANOMA IN THE PRESENCE OF AUTOLOGOUS DENDRITIC CELLS (DC) AND AUTOLOGOUS TUMOR

Schiltz, P M, Malone, C, Mackintosh, A D, Spencer, K S, Dillman, R O

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

67

PHASE I TRIAL OF ADJUVANT VACCINATION WITH TYROSINASE PEPTIDES AND GM-CSF IN MELANOMA

Schmittel, A., Scheibenbogen, C., Servetopoulou, F., Schadendorf, D., Thiel, E., Foerster, M. H., Keilholz, U.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 112 KB

1999

68

BAY 50–4798

Shanafelt, A. B., Carter, C., Dubois-Stringfellow, N., Gibbons, J., Shanafelt, M. -C., Lin, Y.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 114 KB

1999

69

XENOGENEIC DNA IMMUNIZATION WITH TYROSINASE RELATED PROTEIN-2 BREAKS TOLERANCE

Srinivasan, R., Wolchok, J. D., Bowne, W. B., Blachere, Nathalie E., Hawkins, William G., Dyall, Ruben, Lewis, J. J., Houghton, A. N.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 114 KB

1999

70

INCREASED SOLUBLE SUPPRESSIVE FACTORS FOR CELL-MEDIATED IMMUNE REACTION IN PATIENTS WITH ADVANCED CANCER MAY BE DECREASED BY PROTEAS INHIBITORS

Shibata, M., Kanou, H., Nezu, T., Ohara, M., Fukuzawa, M.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 113 KB

1999

71

ACTIVE SPECIFIC IMMUNOTHERAPY WITH COLON TUMOR CELL-LINE EXPRESSING FLT-3 LIGAND & SYSTEMIC IL-2 DECREASED TUMOR INCIDENCE OF MICE WITH SYNGENEIC COLON CANCER

Stavropoulos, C. I., Sivanandham, M., Wallack, M. K.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 114 KB

1999

72

IDENTIFICATION OF NOVEL TUMOR ASSOCIATED ANTIGENS IN MELANOMA PATIENTS RECEIVING ALVAC-IL-12

Bellows, B. R., Conry, R. M., Bonnet, M. C., LoBuglio, A. F., Strong, T. V.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 117 KB

1999

73

HEAT SHOCK PROTEIN, gp96

Yedavelli, S. P.K., Badithe, A., Mittelman, A., Tiwari, R. K.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 117 KB

1999

74

PERITUMORAL TREATMENT OF SINGLE CHAIN INTERLEUKIN-12 (IL-12) NAKED DNA RESULTS IN TUMOR REGRESSION OF ESTABLISHED MURINE LUNG CARCINOMA

Watanabe, M., McCormick, K. L., Wirth, J. H., Roessler, P. G., Wigginton, J. M., Wiltrout, R. H.

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 101 KB

1999

75

RATIONALE FOR IMMUNOANGIOSTATIC APPROACHES TO THE TREATMENT OF MURINE NEUROBLASTOMA

Wigginton, J M, Wiltrout, T A, Smith, J, Back, T C

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 102 KB

1999

76

TETRACYCLINE-CONTROLLED POSITIVE FEEBACK REGULATORY SYSTEM (PFRS)

Journal:

Journla of Immunotherapy

Year:

1999

File:

PDF, 117 KB

1999

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски